ME
About
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes, and kidney disease, orthopedic spine conditions, and cardiovascular disorders.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 705 investors are based in Melbourne, Victoria, Australia.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Melbourne, Australia
Contact Information
Find more investors like Mesoblast
Search Investors